TABLE OF CONTENTS
Volume 4, Issue 6 (2004)
In This Issue |
Clinical Implications |
Meeting Report |
Perspective |
Original Articles
Editorial
Pharmacogenomics in admixed populations: the Brazilian pharmacogenetics/pharmacogenomics network—REFARGEN FREE
G Suarez-Kurtz
Pharmacogenomics J 4: 347-348; doi:10.1038/sj.tpj.6500287
In This Issue
Top of pageClinical Implications
Pharmacogenetic approaches to rheumatoid arthritis FREE
A Taniguchi and N Kamatani
Pharmacogenomics J 4: 350-353; advance online publication, July 13, 2004; doi:10.1038/sj.tpj.6500263
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs FREE
I Zineh, T Gerhard, C L Aquilante, A L Beitelshees, B N Beasley and A G Hartzema
Pharmacogenomics J 4: 354-358; advance online publication, October 12, 2004; doi:10.1038/sj.tpj.6500284
Meeting Report
Pharmacogenetics Research Network and Knowledge Base Fourth Scientific Meeting FREE
A F Davis and R M Long
Pharmacogenomics J 4: 359-361; advance online publication, October 5, 2004; doi:10.1038/sj.tpj.6500277
Perspective
Importance of patient selection when determining the significance of the CYP3A5 polymorphism in clinical trials FREE
R S Foti and M B Fisher
Pharmacogenomics J 4: 362-364; advance online publication, October 12, 2004; doi:10.1038/sj.tpj.6500286
Original Articles
Chronic lithium treatment of B lymphoblasts from bipolar disorder patients reduces transient receptor potential channel 3 levels FREE
S Andreopoulos, M Wasserman, K Woo, P P Li and J J Warsh
Pharmacogenomics J 4: 365-373; advance online publication, August 31, 2004; doi:10.1038/sj.tpj.6500266
Identification of a pharmacogenetic effect by linkage disequilibrium mapping FREE
C-F Xu, K F Lewis, A J Yeo, L C McCarthy, M F Maguire, Z Anwar, T M Danoff, A D Roses and I J Purvis
Pharmacogenomics J 4: 374-378; advance online publication, August 10, 2004; doi:10.1038/sj.tpj.6500268
Differential display polymerase chain reaction reveals increased expression of striatal rat glia-derived nexin following chronic clozapine treatment FREE
V Z Chong, W Costain, J Marriott, S Sindwani, D J Knauer, J-F Wang, L T Young, D MacCrimmon and R K Mishra
Pharmacogenomics J 4: 379-387; advance online publication, September 7, 2004; doi:10.1038/sj.tpj.6500274
Combined actions of zinc and fluoxetine on nicotinic acetylcholine receptors FREE
J García-Colunga, E Vázquez-Gómez and R Miledi
Pharmacogenomics J 4: 388-393; advance online publication, September 7, 2004; doi:10.1038/sj.tpj.6500275
Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant FREE
G P Randolph, J S Simon, M G Arreaza, P Qiu, J E Lachowicz and R A Duffy
Pharmacogenomics J 4: 394-402; advance online publication, September 28, 2004; doi:10.1038/sj.tpj.6500276
